Correlation Between Virax Biolabs and United Therapeutics
Can any of the company-specific risk be diversified away by investing in both Virax Biolabs and United Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Virax Biolabs and United Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Virax Biolabs Group and United Therapeutics, you can compare the effects of market volatilities on Virax Biolabs and United Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Virax Biolabs with a short position of United Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Virax Biolabs and United Therapeutics.
Diversification Opportunities for Virax Biolabs and United Therapeutics
-0.35 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Virax and United is -0.35. Overlapping area represents the amount of risk that can be diversified away by holding Virax Biolabs Group and United Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on United Therapeutics and Virax Biolabs is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Virax Biolabs Group are associated (or correlated) with United Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of United Therapeutics has no effect on the direction of Virax Biolabs i.e., Virax Biolabs and United Therapeutics go up and down completely randomly.
Pair Corralation between Virax Biolabs and United Therapeutics
Given the investment horizon of 90 days Virax Biolabs Group is expected to generate 7.01 times more return on investment than United Therapeutics. However, Virax Biolabs is 7.01 times more volatile than United Therapeutics. It trades about 0.02 of its potential returns per unit of risk. United Therapeutics is currently generating about 0.06 per unit of risk. If you would invest 820.00 in Virax Biolabs Group on August 27, 2024 and sell it today you would lose (619.00) from holding Virax Biolabs Group or give up 75.49% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Virax Biolabs Group vs. United Therapeutics
Performance |
| Timeline |
| Virax Biolabs Group |
| United Therapeutics |
Virax Biolabs and United Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Virax Biolabs and United Therapeutics
The main advantage of trading using opposite Virax Biolabs and United Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Virax Biolabs position performs unexpectedly, United Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in United Therapeutics will offset losses from the drop in United Therapeutics' long position.| Virax Biolabs vs. Eliem Therapeutics | Virax Biolabs vs. HCW Biologics | Virax Biolabs vs. Scpharmaceuticals | Virax Biolabs vs. Milestone Pharmaceuticals |
| United Therapeutics vs. Incyte | United Therapeutics vs. Alnylam Pharmaceuticals | United Therapeutics vs. Ultragenyx | United Therapeutics vs. Apellis Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Other Complementary Tools
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Global Correlations Find global opportunities by holding instruments from different markets |